Evidence map›Paper›PMID 36482407›Full record

Observational studyJournal of neuroinflammation2022

Temporal proteomics of human cerebrospinal fluid after severe traumatic brain injury.

Sandy R Shultz, Anup D Shah, Cheng Huang, Larissa K Dill, Ralf B Schittenhelm, M Cristina Morganti-Kossmann, Bridgette D Semple

Registry-linked trialOpen access · goldAbstract readObservational Study
In one paragraph

Observational study in Journal of neuroinflammation, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06537713 (Diagnostic Role of Serum Testican and Ubiquitin Levels in Patients With Head Trauma), which is not on this map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06537713 completednot on this map

Diagnostic Role of Serum Testican and Ubiquitin Levels in Patients With Head Trauma

TypeobservationalSponsorKanuni Sultan Suleyman Training and Research HospitalRan2020 to 2021Enrolled89ConditionsModerate Traumatic Brain Injury, Testican-1, UbiquitinArmsTestican-1
3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Observational
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Recent Advances in Human Cerebrospinal Fluid Proteomics.Methods in molecular biology (Clifton, N.J.) · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 3 countries.

Sandy R Shultz *Department of Neuroscience, Monash University, Melbourne, VIC, Australia.
Anup D Shah *Monash Proteomics and Metabolomics Facility, Monash University, Clayton, VIC, Australia.
Cheng HuangMonash Proteomics and Metabolomics Facility, Monash University, Clayton, VIC, Australia.
Larissa K DillDepartment of Neuroscience, Monash University, Melbourne, VIC, Australia.
Ralf B SchittenhelmMonash Proteomics and Metabolomics Facility, Monash University, Clayton, VIC, Australia.
M Cristina Morganti-KossmannDepartment of Epidemiology & Preventive Medicine, Monash University, Prahran, VIC, Australia.
Bridgette D SempleDepartment of Neuroscience, Monash University, Melbourne, VIC, Australia. Bridgette.Semple@monash.edu.
Monash University · AUAlfred Health · AUUniversity of Arizona · USUniversity of Melbourne · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The pathophysiology of traumatic brain injury (TBI) requires further characterization to fully elucidate changes in molecular pathways. Cerebrospinal fluid (CSF) provides a rich repository of brain-associated proteins. In this retrospective observational study, we implemented high-resolution mass spectrometry to evaluate changes to the CSF proteome after severe TBI. 91 CSF samples were analyzed with mass spectrometry, collected from 16 patients with severe TBI (mean 32 yrs; 81% male) on day 0, 1, 2, 4, 7 and/or 10 post-injury (8-16 samples/timepoint) and compared to CSF obtained from 11 non-injured controls. We quantified 1152 proteins with mass spectrometry, of which approximately 80% were associated with CSF. 1083 proteins were differentially regulated after TBI compared to control samples. The most highly-upregulated proteins at each timepoint included neutrophil elastase, myeloperoxidase, cathepsin G, matrix metalloproteinase-8, and S100 calcium-binding proteins A8, A9 and A12-all proteins involved in neutrophil activation, recruitment, and degranulation. Pathway enrichment analysis confirmed the robust upregulation of proteins associated with innate immune responses. Conversely, downregulated pathways included those involved in nervous system development, and several proteins not previously identified after TBI such as testican-1 and latrophilin-1. We also identified 7 proteins (GM2A, Calsyntenin 1, FAT2, GANAB, Lumican, NPTX1, SFRP2) positively associated with an unfavorable outcome at 6 months post-injury. Together, these findings highlight the robust innate immune response that occurs after severe TBI, supporting future studies to target neutrophil-related processes. In addition, the novel proteins we identified to be differentially regulated by severe TBI warrant further investigation as potential biomarkers of brain damage or therapeutic targets.

Indexed as

Brain Injuries, TraumaticProteomicsFemaleHumansMaleBiomarkerInflammationNeutrophilProteinSecondary injuryTBI

Identifiers

PMID36482407
PMCPMC9730674
OpenAlexW4311576468

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.